NCT04405765View on ClinicalTrials.gov

Cryopreserved vs. Lyopreserved Stravix as an Adjunct to NPWT in the Treatment of Complex Wounds

PHASE4CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

June 22, 2021

Primary Completion Date

July 7, 2022

Study Completion Date

July 7, 2022

Conditions
Diabetic Wound
Interventions
DEVICE

NPWT and lyopreserved Stravix

Subjects will be treated with NPWT and lyopreserved Stravix

DEVICE

NPWT and cryopreserved Stravix

Subjects will be treated with NPWT and lyopreserved Stravix

Trial Locations (1)

75390

UT Southwestern Medical Center at Dallas, Dallas

Sponsors

Collaborators (1)

Osiris Therapeutics
All Listed Sponsors
collaborator

Osiris Therapeutics

INDUSTRY

lead

University of Texas Southwestern Medical Center

OTHER